ICON

Showing 15 posts of 31 posts found.

Shire signs strategic partnership deal with ICON

January 10, 2012
Research and Development ICON, Shire

Contract research organisation ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to be the sole global provider of …

Pfizer

Pfizer simplifies contract research with Parexel and Icon

May 27, 2011
Research and Development ICON, Parexel, Pfizer, cros

Parexel and Icon have been chosen as Pfizer’s two long-term partners, in a move by the US pharma company to …

Contract research news in brief

January 24, 2011
Research and Development AMRI, Applied Clinical Intelligence, Cenix Bioscience, Clinipace Worldwide, ICON, PPD, Pacific Biomarkers, monoclonal antibody

PPD sets up a monoclonal antibody JV in Singapore, plus updates from Icon plc, Cenix Bioscience, Clinipace Worldwide, Pacific Biomarkers, …

Contract research news in brief

November 26, 2010
Research and Development Chemir Analytical Services, Convergence, Cyanta, ICON, Iris Pharma, PRA, Proteome Sciences, Selcia, chiltern, contract research

Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, …

Contract research news in brief

July 13, 2010
Research and Development Charles River Laboratories, ClinTec, ICON, Quintiles, Synexus, Technical Resources International, WuXi

Charles River places its proposal to merge with China’s WuXi PharmaTech in front of its shareholders, while ClinTec and Synexus …

Contract research news in brief

June 18, 2010
Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research

Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …

Mixed fortunes for major CROs in Q1

May 7, 2010
Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation

Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …

ICON and Tigermed forge China alliance

April 7, 2010
Research and Development CRO, China, ICON

Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …

ICON headquarters

ICON sees revenues rise in 2009

March 1, 2010
Research and Development CRO, ICON

Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …

ICON promotes Tom O’Leary

February 9, 2010
Research and Development ICON, appointment, research and development

Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …

ICON Bruce Given

Bruce Given appointed chairman of ICON

January 18, 2010
Research and Development ICON, appointment, research and development

Irish contract research organisation ICON has appointed Bruce Given chairman.He succeeds out-going chairman John Climax who co-founded the company in 1990 …

Contract research news in brief

December 22, 2009
Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG

Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …

ICON headquarters

ICON investments will come to fruition in 2010

December 16, 2009
Research and Development ICON, Manchester, translational

Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …

Clinical research news in brief

November 30, 2009
Research and Development CRO, Clinipace, ICON, Parexel

Pharmafocus’ latest round-up of clinical research news includes a new US registry to aid patient recruitment, alliances for ICON, Parexel …

Observational studies will help answer growing safety demands

September 8, 2009
Research and Development ICON, drug safety

The pharmaceutical industry is ready to adapt to growing drug safety requirements, but understanding of how it can capture safety …

The Gateway to Local Adoption Series

Latest content